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Pleural Effusion in Michigan Caused by Coccidioides Immitis After 
Ttavel to an Endemic Area 
Christopher W. Hughes, MD,* and Paul A. Kvale, MD* 
Primary coccidioidal disease is rarely diagnosed in the midwest in the nonimmunocompromised host. 
Since coast-to-coast travel is common today, many patients may become exposed to Coccidioides 
immitis while traveling in endemic areas. We present a case of acute coccidioidal pleural effusion in a 
Michigan woman who had recently visited northeastern Arizona. Her travel history was the single 
most important factor in the eventual diagnosis of coccidioidal pleural effusion. (Henry Ford Hosp 
MedJ 1989;37:47-9) 
Coccidioidomycosis is an endemic disease in the south-westem United States, but may be seen in nonendemic loca-
tions due to patients' travels. Pleural effusions caused by Coc-
cidioides immitis occur in about 7% of adult patients during the 
primary infection; the effusions are generally "benign" and re-
quire no specific therapy (1). Coccidioidomycosis should be 
considered in the differential diagnosis of pleural effusion oc-
curring in patients with the proper clinical manifestations and a 
history of travel to an endemic area. 
Case Report 
This previously healthy 47-year-old white female was initially evalu-
ated by her private physician because of left-sided pleuritic chest pain 
after retuming home to Michigan from Arizona. (She had ti-aveled nu-
merous times to Arizona during the preceding six months.) Her clinical 
examination, electrocardiogram, and chest roentgenogram (Fig 1) were 
normal. Two months later the pleuritic chest pain had largely abated, 
but she complained of a pulling and catching in her left hemithorax with 
deep inspiration, associated with general malaise and temperature 
spikes of > 38.3°C (lOrF). She denied cough, dyspnea, wheezing, 
anorexia, chills, night sweats, or skin rashes. She did not smoke, drank 
alcohol socially, and had no significant medical history. There was no 
known exposure to asbestos. She had no unusual hobbies or habits. She 
took no medicines and had no allergies. Physical examination revealed 
an anxious female in no acute distress. Her temperature was 38.TC 
(100.6°F), blood pressure 130/70 mm Hg, heart rate 80 beats/min, and 
respiration 14 breaths/min and unlabored. The left lower hemithorax 
was dull to percussion with decreased breath sounds. The remainder of 
her physical examination was normal; specifically, she had no skin rash. 
Chest roentgenogram revealed a moderate, left-sided pleural effusion 
without lymphadenopathy. Computed tomography (CT) studies of the 
abdomen and thorax were normal except for the pleural effusion; spe-
cifically, there was no hilar or mediastinal lymphadenopathy. There was 
no reaction to PPD and a positive reaction to mumps and Candida con-
trol skin tests. Complete blood count revealed a hemoglobin of 141 g/L 
(14.1 g/dL), WBC count of 8.7 x lO'/L (8,700/fjiL) with 0.07 (7%) 
eosinophils on differential. SMAC results were normal. ANA and 
rheumatoid factor were negative. Thoracentesis revealed straw-colored 
fluid, protein 53 g/L (5.3 g/dL), lactic dehydrogenase 331 U/L, WBC 
count 4.2 X lO'/L (4,160/|xL) with 0.72 (72%) lymphocytes, 0.18 
(18%) monocytes, 0.09 (9%) eosinophils, 0.01 (1%) basophils, 0.15 
(15%) nonhematologic cells, and RBC count 860 x W/L (860/(JLL). 
Cytology of the pleural fluid was negative for malignancy. Pleural bi-
opsy showed noncaseating granulomata. Routine gram stain, culture 
and sensitivity, fungal stain, and acid-fast bacillus (AFB) stain were 
negative for both pleural fluid and biopsies. Fungal and AFB cultures 
were negative. Bronchoscopy and transbronchial biopsy were non-
specific, and neither AFB nor fungi were recovered. The patient was 
placed on 300 mg/day of isonicotinoylhydrazine (INH), 600 mg/day of 
rifampin, and aspirin as needed and was sent to Henry Ford Hospital for 
consultation. 
At our initial evaluation the patient's complaints had largely re-
solved . She no longer had fever and her chest discomfort had improved, 
but she still felt fatigued. On physical examination temperature was 
37°C (98.6°F), blood pressure 130/70 mm Hg, heart rate 80 beats/min, 
and respiration 16 breaths/min and unlabored. Again, the only signifi-
cant physical findings were dullness to percussion and decreased breath 
sounds in the left lower hemithorax. Chest roentgenogram revealed a 
left pleural effusion (Fig 2). CT of the thorax revealed no additional ab-
normalities. A repeat PPD was negative with positive control skin tests. 
The coccidioidal immunodiffusion titers were positive at 1:16 with full 
identity of all bands; complement fixation titers were also positive at 
1:8. Immunodiffusion titers and complement fixation titers for A^-
pergillus, blastomycosis, and histoplasmosis were negative. Repeat 
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Fig 1—Baseline chest x-ray from two years prior to acute ill-
ness. There was no change in the x-ray obtained on first 
presentation. 
Fig 2—Chest x-ray two months after initial presentation reveal-
ing moderate left pleural effusion. 
fungal and AFB cultures of the pleural fluid and pleural biopsies re-
vealed no growth. INH and rifampin were discontinued, and the patient 
continued to improve both clinically and by chest roentgenogram (Fig 
3). On the advice of a third consultant elsewhere she was placed on 400 
mg/day of ketoconazole for the last several months of her course. 
Discussion 
Coccidioidomycosis is caused by a tissue dimorphic soil 
fungus endemic in the desert of southwestem United States, par-
ticularly the San loaquin Valley of Califomia, Arizona, and 
New Mexico (2). Approximately 50,000 persons are infected 
each year, and in susceptible populations about 0.4% per year 
seek medical help for their infections (3). Less than half of the 
patients with primary pulmonary coccidioidomycosis are symp-
tomatic. The most common manifestation is a febrile pulmonary 
illness much like influenza. The most common symptoms asso-
ciated with primary pulmonary infection are cough, fever, and 
chest pain, seen in 70% to 90% of patients (3). Cough is usually 
associated with small amounts of sputum which may be streaked 
with blood. Night sweats may accompany the fever. The chest 
pain (82% of patients) is usually pleuritic. Fatigue and lethargy 
may be profound. Other, less common symptoms seen with the 
primary infection are headache, sore throat, diffuse muscle 
aches, and loss of appetite (3). 
Over one-third of the patients have peripheral eosinophilia 
and one-half have erythema nodosum or erythema multiforme 
(4). Erythema nodosum is especially common in women. Our 
patient denied any form of skin rash, which may have given 
other physicians a better clue to the correct diagnosis earlier. 
Erythema multiforme and toxic erythema (a diffuse mac-
ulopapular emption) are additional dermatologic manifestations 
commonly seen with primary coccidioidal pulmonary infec-
tions. Typical "valley fever" consists of erythema nodosum or 
erythema multiforme plus arthralgias or arthritis and sometimes 
mild conjunctivitis. 
Most patients with primary coccidioidomycosis have abnormal 
chest roentgenograms. Alveolar infiltrates are the most common, 
usually seen in one segment or lobe, extending to the visceral 
pleura in all cases (1). Atelectasis is also common. Hilar adenopa-
thy is seen in 20% of cases, usually ipsilateral to the infiltrate. 
Again, these clues to the diagnosis were lacking in our patient, per-
haps because of die fortuitous timing when chest roentgenograms 
were obtained. Although small pleural effusions may be seen in 
20% of patients, larger pleural effusions are seen in only 2% to 6% 
of patients (3). The effusions are unilateral and represent a para-
pneumonic process rather than an extrathoracic dissemination. 
Davies (2) states that sterile pleural effusions and pleurisy occur in 
5% to 10% of cases and likely represent hypersensitivity rather than 
infection. Pleural effusions may also occur in the chronic form of 
coccidioidomycosis, but often represent empyema with or without 
bronchopleural fistula contributing to an increased acute and 
chronic morbidity (4). 
Serologic studies are extremely important in establishing a 
definitive diagnosis, particularly in the absence of recovery of 
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the organism on cultures or stains of body fluids or tissues. The 
coccidioidin skin test is usually positive and serum complement 
fixation titers are elevated (> 1:16) (4). In our patient the immu-
nodiffusion test was positive with fufi identity to all coccidioidin 
bands at a titer of 1:16 during the time she presented to us. Fol-
low-up serology was not possible since she chose to go else-
where for continuing care. The immunodiffusion test we em-
ployed largely measures IgG precipitating antibodies, with the 
patient's semm being matched with a known positive control to 
Coccidioides immitis. The antigen is an "F" antigen, which is a 
mycelial filtrate and predominantly measures IgG antibody. The 
serum was sent to the Michigan Department of Public Health, 
where a complement fixation test was also positive at a titer of 
1:8. This is significant because the complement fixation test es-
sentially uses the same antigen that we use (the "F" antigen) in 
the immunodiffusion test. The complement fixation test is more 
sensitive, but less specific. Our patient's semm was negative for 
Aspergillus, blastomycosis, and histoplasmosis on immu-
nodiffusion testing, and negative to blastomycosis and histo-
plasmosis at the Michigan Department of Public Health for com-
plement fixation antibodies. There is much less cross-reactivity 
with the immunodiffusion test since we can monitor the bands of 
identity. With full identity, such as was demonstrated in our lab-
oratory, we can confidently conclude that the patient had a 
positive serologic test for coccidioidomycosis. "TP" antibody 
(an IgM antibody) was not tested in our laboratory. 
The pleural fluid findings in our patient were those of any non-
specific granulomatous pleuritis. Although Coccidioides immi-
tis is often recovered from pleural biopsy (and less frequently 
from pleural fluid), we were unable to recover these organisms 
from our patient. However, the serologic studies discussed allow 
for a confident diagnosis of the pleural effusion caused by infec-
tion with Coccidioides immitis. 
The course of primary pulmonary coccidioidomycosis is typ-
ically benign, and symptoms resolve without specific therapy 
unless dissemination or relapse occurs. Even when pleural effu-
sions accompany the primary infection, treatment is rarely nec-
essary; fluid resolution is slow, often taking one to eight weeks 
(1). Our patient received ketoconazole therapy from a third con-
sultant, a recommendation with which we did not concur. 
Whether or not the addition of ketoconazole to her management 
approach helped resolve her pleural effusion more rapidly is 
conjectural. In a study of a large series of patients with pleural 
effusions, results showed that the effusions almost always 
resolved spontaneously without the addition of specific antifun-
gal treatment (1). When the course suggests more complicated 
disease (eg, persistent effusion with rising complement fixa-
tion titers and a negative coccidioidal skin test), systemic 
Fig 3—Follow-up chest x-ray showing resolution of left pleural 
effusion. 
amphotericin B should be employed. The utility of ke-
toconazole in the setting of a pleural effusion accompanying pri-
mary pulmonary coccidioidomycosis has not yet been 
determined. 
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